Marker Therapeutics Inc (MRKR)

[attilathehunt]

"Right now, if I had this disease, I would choose multi-TAA +anti-PD1/CTLA4. I'd sign up for that trial, especially if they added WT-1 to the pep mix."

I believe the vast majority of pancreatic patients/ families would elect to choose multi-TAA. With that said, what will be the next step? At this point, what is more humane? Continue trials for further safety and efficacy reasons or provide realistic hope for many? I would think those that have to make the decision have friends, peers, family or acquaintances that would benefit if made available (even if conditionally) so IMO, the safety of the process would make it a safe decision to offer some type of accelerated approval. At least petition FDA to find out what more do they need in light of the incredible safety features and very promising efficacy profile.